Description

GHK-Cu 50mg + TB-500 10mg + BPC-157 10mg + KPV 10mg Blend

Advanced Multi-Peptide Research Formulation | 80mg Total Peptide Material

The GHK-Cu 50mg + TB-500 10mg + BPC-157 10mg + KPV 10mg Blend combines four distinct peptide compounds in one research formulation.

The blend contains 50mg GHK-Cu, 10mg TB-500, 10mg BPC-157, and 10mg KPV. Together, these components provide a stated total of 80mg peptide material.

Each peptide has a different molecular structure and research profile. Therefore, researchers can study the individual components and compare them within the complete formulation.

GHK-Cu 50mg + TB-500 10mg + BPC-157 10mg + KPV 10mg Composition

Peptide Amount
GHK-Cu 50mg
TB-500 10mg
BPC-157 10mg
KPV 10mg
Total Peptide Material 80mg

The stated quantities describe the product formulation. However, the exact purity, chemical form, and batch characteristics may vary. Therefore, researchers should always check the product label and batch-specific COA.

GHK-Cu 50mg Research Profile

GHK-Cu is a copper-binding peptide studied in laboratory research. Researchers examine GHK-Cu in areas such as cellular signaling, extracellular-matrix biology, peptide chemistry, and skin-related research.

In addition, laboratories can evaluate GHK-Cu for identity, purity, molecular characteristics, and stability.

Therefore, GHK-Cu provides one defined component for analytical and comparative peptide research.

TB-500 10mg Research Profile

TB-500 is a peptide research material associated with the thymosin beta-4 research area.

Researchers have investigated TB-500 in studies involving peptide chemistry, cell migration, actin-related processes, and tissue biology. However, experimental findings can vary between research models.

For this reason, laboratories should evaluate the exact material using appropriate analytical methods and batch documentation.

BPC-157 10mg Research Profile

BPC-157 is a synthetic pentadecapeptide that researchers have studied mainly in preclinical models.

Research has examined BPC-157 in areas such as cellular signaling, peptide chemistry, molecular characterization, and experimental tissue models.

In addition, researchers can analyze BPC-157 for identity, purity, molecular mass, and stability. However, preclinical findings should remain within the specific experimental context.

KPV 10mg Research Profile

KPV is a short peptide derived from the C-terminal region of alpha-melanocyte-stimulating hormone (α-MSH).

Researchers have investigated KPV in laboratory studies involving inflammatory and immune-related signaling pathways.

Furthermore, laboratories can characterize KPV through peptide identification, purity testing, stability analysis, and molecular characterization.

Four-Component Research Formulation

This formulation brings together four different peptide materials.

First, GHK-Cu provides the copper-binding peptide component.

Next, TB-500 adds a separate peptide research component.

Then, BPC-157 contributes another defined peptide for laboratory investigation.

Finally, KPV completes the four-component formulation.

As a result, researchers can compare the individual peptides and examine the complete blend under controlled laboratory conditions.

Research Applications

Researchers may investigate this formulation in several areas. For example:

  • Peptide chemistry
  • Cellular signaling
  • Extracellular-matrix research
  • Molecular characterization
  • Cell migration studies
  • Inflammatory pathway research
  • Immune-related research
  • Skin biology research
  • Analytical chemistry
  • Purity testing
  • Peptide stability studies
  • Formulation research
  • Comparative peptide research

In addition, laboratories can analyze each component separately before they evaluate the full formulation.

Key Characteristics

Four-Component Peptide Blend

The formulation combines GHK-Cu, TB-500, BPC-157, and KPV in one research preparation. Each component maintains its own molecular identity.

Defined 80mg Composition

The formulation contains 50mg GHK-Cu, 10mg TB-500, 10mg BPC-157, and 10mg KPV. Therefore, the total listed peptide content equals 80mg.

Distinct Peptide Components

Each peptide has different structural and analytical characteristics. Consequently, researchers can use suitable component-specific methods during laboratory analysis.

Comparative Research Utility

Researchers can examine the individual components and compare their characteristics with the complete multi-peptide formulation.

Furthermore, analytical testing can help researchers evaluate the consistency of the finished blend.

Product Specifications

Product Name: GHK-Cu 50mg + TB-500 10mg + BPC-157 10mg + KPV 10mg Blend
GHK-Cu: 50mg
TB-500: 10mg
BPC-157: 10mg
KPV: 10mg
Total Peptide Material: 80mg
Product Type: Multi-peptide research formulation
Research Areas: Peptide, cellular, molecular, and analytical research
Intended Application: Laboratory and analytical research

Quality & Documentation

Good research documentation helps laboratories verify the supplied material. For example, documentation may include:

  • Individual peptide identity
  • Component quantities
  • Purity or assay results
  • Batch or lot number
  • Certificate of Analysis (COA)
  • Analytical test results
  • Stability information
  • Product specifications

Therefore, researchers should compare the product label with the applicable batch documentation before analytical work.

Analytical Characterization

Because the formulation contains four different peptides, laboratories can analyze each component separately.

Depending on the research protocol, testing may include:

  • Identity confirmation
  • Purity analysis
  • Molecular characterization
  • Individual peptide content
  • Stability testing
  • Degradation analysis
  • Formulation consistency
  • Analytical method development

In this way, researchers can distinguish the characteristics of GHK-Cu, TB-500, BPC-157, and KPV within the combined formulation.

Research and Formulation Notes

The four peptides have different molecular structures and research backgrounds. Therefore, researchers should evaluate each component independently as well as the complete blend.

However, research findings for an individual peptide do not automatically establish the properties of the combined formulation.

In addition, product composition and quality can vary between batches. For that reason, researchers should use the specific product label and batch-specific COA as the primary reference.

Important Research Information

This product is presented as a multi-peptide research formulation for laboratory and analytical applications.

Each component has its own molecular identity. Therefore, researchers should document the components separately and evaluate the complete formulation using appropriate laboratory procedures.

This information is provided for scientific, analytical, product-identification, and legitimate laboratory research purposes. It does not provide dosing, administration, treatment, or performance-enhancement instructions.